IL-8, IL-10, TGF-, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment
Open Access
- 19 December 2012
- journal article
- research article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2012, 1-8
- https://doi.org/10.1155/2012/720976
Abstract
Background. Allergic asthma is showed an increase in Th2-cytokine and IgE levels and an accumulation activation of Th2 cells, eosinophils and mast cells. However, recent studies focused on cell-based mechanisms for the pathogenesis of allergic asthma.Objectives. In this study, we compare the anti-IgE treatment modality in the dynamics of immune system cytokine levels in severe persistent asthma (SPA) patients who had no other any allergic disease, newly diagnosed allergic asthma patients and healthy volunteers.Study Design. The study population consisted of 14 SPA patients, 14 newly diagnosed allergic asthma patients and 14 healthy volunteers included as controls. Cytokine levels were measured. Total and specific IgE levels of anti-IgE monoclonal antibody treated patients, serum high-sensitivity C-reactive protein (hsCRP) levels, FEV1/FVC rates and asthma control test (ACT) were measured for the clinical follow-up.Results. We observed that SPA patients presented increasing levels of IL-8, IL-10, TGF-βand GCSF during the anti-IgE treatment in period of sampling times at 4 months and 18 months. However this increase was not correlated neither with serum hsCRP levels nor FEV1/FVC rates.Conclusions. Our study gives a different perspective for the SPA and anti-IgE immunotherapy efficacy at the cell cytokine-linked step.Keywords
This publication has 46 references indexed in Scilit:
- The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumabMedical Science Monitor, 2012
- Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatmentMedical Science Monitor, 2012
- A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthmaThe Journal of Experimental Medicine, 2010
- Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPDThorax, 2009
- Eosinophils in the pathogenesis of allergic airways diseaseCellular and Molecular Life Sciences, 2007
- Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patientsAnnals of Allergy, Asthma & Immunology, 2006
- Omalizumab decreased IgE‐release and induced changes in cellular immunity in patients with allergic asthmaAllergy, 2006
- Serum interferon-γ is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging StudyAnnals of Allergy, Asthma & Immunology, 2003
- The association of sensitive systemic inflammation markers with bronchial asthmaAnnals of Allergy, Asthma & Immunology, 2002
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaThe New England Journal of Medicine, 1992